Based on this observation and since SB216763 reduced GSK3β/N1-ICD interactions while increased N1-ICD stability in CLL cells, we hypothesized that GSK3β/N1-ICD interactions might be important for targeting N1-ICD towards the ubiquitin-proteasome pathway. The gene discussed is GSK3B; the disease is B-cell chronic lymphocytic leukemia.